Open session
10:00 // João Moura (P-BIO Board and BIOCANT President)
Clinical Development
10:15 // Public presentation of the study “Clinical Development Road Map” – Francisco Batel Marques (AIBILI – “Technology Assessment Center for Health Research and Medicines” Director) – responsible for the study
11:00 – 11:15 // Coffee Break
11:15 – 12:30 // “Clinical Development Road Map” study debate
Moderation of the debate: Francisco Batel Marques (responsible for the study)
Sérgio Simões – Blueclinical and P-BIO board
Aleixo Dias – PFZIER Medical Director
João Pereira – Magnomics Chief Executive Office
Alexandre Lourenço – Portuguese Hospital Managers Association President
INFARMED I.P. “National Authority of Medicines and Health Products” board member to designate (tbc)
13:00 // Lunch – with prior registration
Location: BIOCANT ½ day (Morning and lunch)
Side event // BIOCANT Junior Science Center
Register for free by September 23: smonteiro@p-bio.org